← Back to brief

Source archive

MIT Technology Review / AI

MIT Technology Review is a technology publication founded by the Massachusetts Institute of Technology. Its AI coverage combines reporting and analysis on research, companies, policy, products, and the wider consequences of artificial intelligence.

3 AISurfing briefingsVisit official source ↗

Briefings where MIT Technology Review / AI is the primary source

Policy SafetyReportedMIT Technology Review / AI

Meet GPT-Red: an LLM super-hacker OpenAI built to make its models safer

OpenAI has developed GPT-Red, a large language model designed to act as a super-hacker sparring partner to improve the security of its other models. According to the company, training its latest flagship model, GPT-5.6, against GPT-Red resulted in its most robust release yet.

Why it matters: This approach uses one LLM to automatically red-team another, representing a novel method for improving AI model robustness and safety.

Jul 15, 2026

ResearchReportedMIT Technology Review / AI

Anthropic Unveils Hidden Conceptual Space in Claude Using Jacobian Lens

Anthropic has developed a technique called the Jacobian lens that provides the clearest view yet of how large language models like Claude process information internally. Their findings reveal a hidden conceptual space within the model, with insights ranging from the mundane to the unnerving.

Why it matters: This breakthrough offers unprecedented transparency into AI reasoning, which could improve the safety and interpretability of large language models.

Jul 10, 2026

Products AgentsReportedMIT Technology Review / AI

Anthropic Launches Claude Science for Autonomous Scientific Research

Anthropic has announced Claude Science, a new product aimed at supporting scientific research by autonomously performing meaningful tasks from high-level instructions. The announcement took place at an event attended by pharmaceutical executives, biotech founders, and researchers.

Why it matters: Claude Science represents Anthropic's move into automating scientific research, which could accelerate progress in areas such as drug development.

Jul 10, 2026